Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/09/24 | Current report filing |
|
 |
5 | |
| 09/24/24 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | ||
| 09/24/24 | Current report filing |
|
|
22 | |
| 09/24/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 09/17/24 | Current report filing |
|
|
51 | |
| 08/23/24 | Initial statement of beneficial ownership of securities |
|
1 | ||
| 08/23/24 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | ||
| 08/09/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/08/24 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
50 | |
| 08/07/24 | Current report filing |
|
|
8 |